Early surgery and survival of patients with anaplastic thyroid carcinoma: Analysis of a case series referred to a single institution between 1999 and 2012

Thyroid

Volumn 24, Issue 11, 2014, Pages 1600-1606

  Brignardello, Enrico ^a   Palestini, Nicola ^a   Felicetti, Francesco ^b   Castiglione, Anna ^a   Piovesan, Alessandro ^a   Gallo, Marco ^a   Freddi, Milena ^a   Ricardi, Umberto ^b   Gasparri, Guido ^b   Ciccone, Giovannino ^a   Arvat, Emanuela ^b   Boccuzzi, Giuseppe ^b  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CISPLATIN; DOXORUBICIN; PACLITAXEL; VITAMIN D;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASPIRATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE STUDY; CATHETER INFECTION; CHEMORADIOTHERAPY; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; DISTANT METASTASIS; EARLY INTERVENTION; ESOPHAGITIS; FEMALE; GASTROSTOMY; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; LARYNX EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; OFF LABEL DRUG USE; OVERALL SURVIVAL; PARENTERAL NUTRITION; QUALITY OF LIFE; RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SEROMA; STERNOTOMY; SURVIVAL RATE; SURVIVAL TIME; THYROID CARCINOMA; TRACHEOSTOMY; UNSPECIFIED SIDE EFFECT; VENA CAVA FILTER; ADJUVANT THERAPY; MIDDLE AGED; MORTALITY; PROGNOSIS; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84910609828     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0004     Document Type: Article

References (20)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83: 2638-2648.
2. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR 2001 Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130:1028-1034.
3. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A 2005 Anaplastic thyroid carcinoma. Treat-ment outcome and prognostic factors. Cancer 103:1330-1335.
4. Smallridge RC, Copland JA 2010 Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) 22:486-497.
5. Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ 2013 Marginal treatment benefit in anaplastic thyroid cancer. Cancer 119:3133-3139.
6. Are C, Shaha AR 2006 Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13:453-464.
7. Pudney D, Lau H, Ruether JD, Falck V 2007 Clinical experience of the multimodality management of anaplastic thyroid cancer and literature review. Thyroid 17:1243-1250.
8. Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J 2012 Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors. Head Neck 34:230-237.
9. Smallridge RC 2012 Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab 97: 2566-2572.
10. Swaak-Kragten AT, de Wilt JH, Schmitz PI, Bontenbal M, Levendag PC 2009 Multimodality treatment for anaplastic thyroid carcinoma-treatment outcome in 75 patients. Radiother Oncol 92:100-104.
11. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH 2001 Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335-2342.
12. Machens A, Hinze R, Lautenschläger C, Thomusch O, Dunst J, Dralle H 2001 Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid 11:373-380.
13. Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K 2002 The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245-248.
14. Brignardello E, Gallo M, Baldi I, Palestini N, Piovesan A, Grossi E, Ciccone G, Boccuzzi G 2007 Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur J Endocrinol 156:425-430.
15. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM 2012 American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22:1104-1139.
16. Chen J, Tward JD, Shrieve DC, Hitchcock YJ 2008 Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. Am J Clin Oncol 31:460-464.
17. Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K 2011 Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 21:1183-1189.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) 2010 AJCC Cancer Staging Manual. Seventh edition. Springer, New York, NY, pp 87-96.
19. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S 2012 Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 36:1247-1254.
20. Sherman EJ, Lim SH, Ho AL, Ghossein RA, Fury MG, Shaha AR, Rivera M, Lin O, Wolden S, Lee NY, Pfister DG 2011 Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. Radiother Oncol 101:425-430.